Klimowich John
Transaction: 10/02/2026
BUY
Change
—
Price
$11.41
Filing
10/06/2026
Type
BUY


The latest report is predominantly positive and shows an overall improvement in financial performance. Revenue and profitability advanced at a meaningful pace, while the weaker areas should be reviewed in context. The report may attract increased investor attention and price volatility.
Key valuation, quality, financial strength, momentum and analyst data.
How strong this company looks for long-term investors
Analyst sentiment and price target
Recent executive and insider activity
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Klimowich John | BUY | — | $11.41 | 10/02/2026 | 10/06/2026 |
| Holland Noel R. | BUY | — | $11.41 | 10/02/2026 | 10/06/2026 |
| Kemly Thomas J. | BUY | — | $11.41 | 10/02/2026 | 10/06/2026 |
| Kemly Thomas J. | BUY | — | $11.58 | 09/18/2026 | 09/22/2026 |
| Klimowich John | BUY | — | $11.58 | 09/18/2026 | 09/22/2026 |
| Holland Noel R. | BUY | — | $11.70 | 09/04/2026 | 09/09/2026 |
| Kemly Thomas J. | BUY | — | $11.70 | 09/04/2026 | 09/09/2026 |
| Klimowich John | BUY | — | $11.70 | 09/04/2026 | 09/09/2026 |
| Holland Noel R. | SELL | -20 | Not reported | 09/03/2026 | 09/04/2026 |
| Gibney Dennis E. | BUY | — | $11.62 | 08/26/2026 | 08/28/2026 |
| Randall Elizabeth E. | BUY | — | $11.62 | 08/26/2026 | 08/28/2026 |
| Klimowich John | BUY | +39 | $11.62 | 08/26/2026 | 08/28/2026 |
| Kemly Thomas J. | BUY | +392 | $11.62 | 08/26/2026 | 08/28/2026 |
| Holland Noel R. | BUY | — | $11.62 | 08/26/2026 | 08/28/2026 |
| Lewis Oliver Edward Jr | BUY | +6 | $11.62 | 08/26/2026 | 08/28/2026 |
| Sorrentini Lucy | BUY | — | $11.62 | 08/26/2026 | 08/28/2026 |
| Schlesinger Allyson Katz | BUY | +44 | $11.62 | 08/26/2026 | 08/28/2026 |
| Prabhu Manesh Balachandran | BUY | — | $11.62 | 08/26/2026 | 08/28/2026 |
| Kemly Thomas J. | BUY | — | $11.79 | 08/21/2026 | 08/25/2026 |
| Klimowich John | BUY | — | $11.79 | 08/21/2026 | 08/25/2026 |